These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32927918)

  • 1. How Should We Assign Large Infiltrative Hepatocellular Carcinomas for Staging?
    Lee YJ; Lee YR; Seo CG; Goh HG; Kim TH; Yim SY; Han NY; Lee JM; Choi HS; Kim ES; Keum B; An H; Park B; Seo YS; Yim HJ; Kim JH; Yu YD; Kim DS; Jeen YT; Chun HJ; Lee HS; Kim CD; Um SH
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32927918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma.
    Chun YH; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Kim BK; Choi GH; Kim KS; Choi JS; Ahn SH
    Eur J Cancer; 2011 Nov; 47(17):2568-75. PubMed ID: 21835608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up-to-seven criteria.
    Wang YY; Zhong JH; Xu HF; Xu G; Wang LJ; Xu D; Wang HW; Wang K; Xiang BD; Mao YL; Li LQ; Xing BC
    Aliment Pharmacol Ther; 2019 Jan; 49(2):202-210. PubMed ID: 30506713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
    Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
    J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
    Minagawa M; Ikai I; Matsuyama Y; Yamaoka Y; Makuuchi M
    Ann Surg; 2007 Jun; 245(6):909-22. PubMed ID: 17522517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical appraisal of TNM versus HKU staging system for postoperative prognostic evaluation of hepatocellular carcinoma.
    She WH; Chan ACY; Ma KW; Dai WC; Chok KSH; Cheung TT; Lo CM
    Ann Transl Med; 2021 Jun; 9(11):919. PubMed ID: 34350234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of the outcomes of surgical resection for intermediate and advanced Barcelona Clinic Liver Cancer stage hepatocellular carcinoma: A critical appraisal of the evidence.
    Koh YX; Tan HL; Lye WK; Kam JH; Chiow AKH; Tan SS; Choo SP; Chung AYF; Goh BKP
    World J Hepatol; 2018 Jun; 10(6):433-447. PubMed ID: 29988922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
    Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS
    J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
    Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
    Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.
    Goh BK; Teo JY; Chan CY; Lee SY; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 Jan; 113(1):89-93. PubMed ID: 26611492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
    Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
    BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
    Tsilimigras DI; Bagante F; Sahara K; Moris D; Hyer JM; Wu L; Ratti F; Marques HP; Soubrane O; Paredes AZ; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Ann Surg Oncol; 2019 Oct; 26(11):3693-3700. PubMed ID: 31267302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status.
    Cho HJ; Kim SS; Kang SY; Yang MJ; Noh CK; Hwang JC; Lim SG; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim JH; Cho SW; Cheong JY;
    Gut Liver; 2019 Sep; 13(5):557-568. PubMed ID: 31023007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of CT follow-up interval on stages of hepatocellular carcinomas detected during the surveillance of patients with liver cirrhosis.
    Chung YE; Kim MJ; Park MS; Choi JY; Lim JS; Kim KA; Kim KW
    AJR Am J Roentgenol; 2012 Oct; 199(4):816-21. PubMed ID: 22997373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the American Joint Committee on Cancer eighth edition staging system in patients undergoing hepatectomy for hepatocellular carcinoma: a US population-based study.
    Zhang G; Li R; Zhao X; Meng S; Ye J; Zhao L
    J Surg Res; 2018 Feb; 222():55-68. PubMed ID: 29273376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative performances of staging systems for early hepatocellular carcinoma.
    Nathan H; Mentha G; Marques HP; Capussotti L; Majno P; Aldrighetti L; Pulitano C; Rubbia-Brandt L; Russolillo N; Philosophe B; Barroso E; Ferrero A; Schulick RD; Choti MA; Pawlik TM
    HPB (Oxford); 2009 Aug; 11(5):382-90. PubMed ID: 19768142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
    Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH
    Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of hepatocellular carcinoma.
    Duseja A
    J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S74-9. PubMed ID: 25755615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study.
    Huang Q; Chen Y; Lin K; Sun C; Zheng S; Chen J; Wang Y; Zhou Y; Zhou W; Liu J; Zeng Y
    Front Oncol; 2021; 11():673285. PubMed ID: 34722235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.